In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian FDA moves toward easing restrictions on certain peptides BioPharma Dive Is BPC 157 Legal? Understanding Its Status and Implications